LOS ANGELES, March 12, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient’s response to cancer therapy, will announce its fourth quarter and year-end financial results for 2013 and give an operational update in a press release to be issued before the market opens on Thursday, March 20, 2014. The company will host a conference call that same day at 10:00 a.m. EDT to discuss its financial results.
Help employers find you! Check out all the jobs and post your resume.
